11 Feb 2021 Governance

Why I became a Leukaemia UK Trustee

This Trustees’ Week, Caroline Evans – Leukaemia UK Trustee and Projects Consultant – reflects on why she became a Trustee for the charity and what drives her in the role.

My family – like many others – has been affected by leukaemia. In 1967, when I was five, my stepbrother, Ashley, died from leukaemia. He was eight years old. Later, as a teenager, I was working in our local pub when the landlady – Isobel Mitchell – was diagnosed with leukaemia and was treated at King’s College Hospital in London. And just two years ago the daughter of a very close friend benefited from innovative and pioneering CAR-T therapy at King’s. Very happily, she has recovered and is now halfway through her second year at university. Our understanding of, and treatment for, leukaemias and other blood cancers have come a very long way in 50 years.

My connection to the cause

My connection with Leukaemia UK started in 1977 when, following Isobel’s death, my dad was involved in establishing a charity to support the work at King’s College Hospital. That charity, then called ELF, later evolved into Leukaemia UK. Dad continued as a trustee for nearly 40 years (which, if I’m honest, is around 30 years too long to be a trustee at the same charity!).

Drawing on insights and expertise

When dad stood down, I applied to join the board to continue the connection and I’ve been a trustee of Leukaemia UK since 2016. Professionally I’m a projects director with a background in education, publishing, engineering and communications. Over the years I have set up and run small businesses and charities. I now focus mainly on the charity sector and I hope to support Leukaemia UK by drawing on the insights and expertise that I’ve developed through my work.

Serving as a trustee gives me immense personal benefit too. One of the great pleasures is the opportunity that it brings to work with people from different sectors and with very different expertise. I enjoy the variety of our board and the challenge that arises from our mix of perspectives. I’ve learnt a great deal from all my colleagues at Leukaemia UK – both trustees and the executive team

Brilliant and loyal supporters

It’s an exciting time for Leukaemia UK. A merger in 2019 brought together two of the UK’s leading leukaemia and blood cancer charities (Leuka and Leukaemia UK) to create a new charity with greater profile, depth and reach. The merger has given us the opportunity to reflect and reset our vision and strategy to ensure that we make the best use of our resources to meet the needs of the sector. Resetting our strategy is a delicate balance, however, because we need to ensure that we continue to inspire and engage the brilliant and loyal supporters and partners of both historic charities, while also reflecting the changing needs of, and opportunities in, the sector.

Looking to the future

We’ve come a long way in the 40 or so years since the foundation of our two historic charities, but there’s still work to be done. Thanks to advancements in research progress is being made, but further research is still urgently needed to develop kinder and more effective treatments for blood cancer. I feel privileged, as a trustee, to be able make a small contribution to the work of Leukaemia UK and its ambition to improve the experience of everyone affected by leukaemia and blood cancers.

Caroline Evans, Leukaemia UK Trustee and Projects Consultant

Related posts

Only 14% of Brits know the warning signs of leukaemia as thousands are diagnosed in A&E every year.

2 September 2024

Only 14% of Brits know the warning signs of leukaemia as thousands are diagnosed in A&E every year.

Leukaemia Care and Leukaemia UK are highlighting the urgent need to raise awareness of signs and symptoms to stop the deadly blood cancer devastating lives. New research has revealed that…

Leukaemia UK launches new Patient Care Pioneer Award funding initiative

19 February 2024

Leukaemia UK launches new Patient Care Pioneer Award funding initiative

Leukaemia UK is delighted to launch a brand-new funding scheme in 2024, intended specifically for innovative, patient-focussed applied research and targeting UK-based healthcare professionals.   The first of its kind for…

Together we are changing lives – Here’s how your support is making it happen

3 July 2025

Together we are changing lives – Here’s how your support is making it happen

At this point in our advocacy journey, we wanted to share an update to you, our supporters, on everything we’ve achieved so far and what’s next as we continue to…

Angela Smith-Morgan to step down from her role as Co CEO of Leukaemia UK

25 August 2020

Angela Smith-Morgan to step down from her role as Co CEO of Leukaemia UK

After eight successful years with us, Angela Smith-Morgan will be stepping down from her role as Co CEO of Leukaemia UK on 3rd September.